Literature DB >> 23898981

Identification of mild cognitive impairments in cancer survivors.

Mary F Baxter1, Andrea N Dulworth, Theresa M Smith.   

Abstract

ABSTRACT Changes in cognitive functioning are a frequent complaint of persons diagnosed and treated for cancer. The purposes of this study were to explore the feasibility of the use of the Montreal Cognitive Assessment (MoCA) for identifying mild cognitive impairment in persons who are cancer survivors as well as begin to identify the prevalence of mild cognitive impairment in cancer survivors as identified by the MoCA. Thirty-eight cancer survivors participated in this study, and 14 scored below the cutoff score of 26 on the MoCA, which indicated mild cognitive impairment. These results indicate assessment of cognitive changes in cancer patients and survivors should be part of the occupational therapy evaluation and that the MoCA is a feasible tool for such use.

Entities:  

Year:  2010        PMID: 23898981     DOI: 10.3109/07380577.2010.533251

Source DB:  PubMed          Journal:  Occup Ther Health Care        ISSN: 0738-0577


  5 in total

1.  Exploring the measurement properties of the Montreal Cognitive Assessment in a population of people with cancer.

Authors:  Giovanni G Arcuri; Lisa Palladini; Gabrielle Dumas; Josée Lemoignan; Bruno Gagnon
Journal:  Support Care Cancer       Date:  2015-02-14       Impact factor: 3.603

2.  The role of depression in the relationship between cognitive decline and quality of life among breast cancer patients.

Authors:  Jin-Hee Park; Yong Sik Jung; Young-Mi Jung; Sun Hyoung Bae
Journal:  Support Care Cancer       Date:  2018-11-29       Impact factor: 3.603

3.  Hybrid Tele and In-Clinic Occupation Based Intervention to Improve Women's Daily Participation after Breast Cancer: A Pilot Randomized Controlled Trial.

Authors:  Khawla Loubani; Rachel Kizony; Uzi Milman; Naomi Schreuer
Journal:  Int J Environ Res Public Health       Date:  2021-06-02       Impact factor: 3.390

Review 4.  Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.

Authors:  Ana Dias-Carvalho; Mariana Ferreira; Rita Ferreira; Maria de Lourdes Bastos; Susana Isabel Sá; João Paulo Capela; Félix Carvalho; Vera Marisa Costa
Journal:  Arch Toxicol       Date:  2021-11-02       Impact factor: 5.153

Review 5.  Episodic Memory and Recollection Network Disruptions Following Chemotherapy Treatment in Breast Cancer Survivors: A Review of Neuroimaging Findings.

Authors:  Meenakshie Bradley-Garcia; Gordon Winocur; Melanie J Sekeres
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.